Have a feature idea you'd love to see implemented? Let us know!

PODD Insulet Corp

Price (delayed)

$231.84

Market cap

$16.26B

P/E Ratio

41.03

Dividend/share

N/A

EPS

$5.65

Enterprise value

$16.83B

Insulet Corporation , headquartered in Massachusetts, is an innovative medical device company dedicated to simplifying life for people with diabetes and other conditions through its Omnipod product platform. The Omnipod ...

Highlights
PODD's price to earnings (P/E) is 99% lower than its 5-year quarterly average of 2816.4 and 35% lower than its last 4 quarters average of 63.2
The equity has soared by 80% YoY and by 26% QoQ
Insulet's quick ratio has increased by 13% YoY but it has decreased by 2.8% from the previous quarter

Key stats

What are the main financial stats of PODD
Market
Shares outstanding
70.12M
Market cap
$16.26B
Enterprise value
$16.83B
Valuations
Price to book (P/B)
16.26
Price to sales (P/S)
8.67
EV/EBIT
54.95
EV/EBITDA
44.09
EV/Sales
8.99
Earnings
Revenue
$1.87B
EBIT
$306.3M
EBITDA
$381.8M
Free cash flow
$157.3M
Per share
EPS
$5.65
Free cash flow per share
$2.25
Book value per share
$14.25
Revenue per share
$26.73
TBVPS
$38.99
Balance sheet
Total assets
$2.88B
Total liabilities
$1.88B
Debt
$1.4B
Equity
$998.4M
Working capital
$1.26B
Liquidity
Debt to equity
1.4
Current ratio
3.6
Quick ratio
2.41
Net debt/EBITDA
1.51
Margins
EBITDA margin
20.4%
Gross margin
69%
Net margin
21.1%
Operating margin
14.6%
Efficiency
Return on assets
15%
Return on equity
50.5%
Return on invested capital
11.3%
Return on capital employed
12.8%
Return on sales
16.4%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

PODD stock price

How has the Insulet stock price performed over time
Intraday
1.09%
1 week
-0.34%
1 month
5.8%
1 year
60.31%
YTD
6.85%
QTD
-0.39%

Financial performance

How have Insulet's revenue and profit performed over time
Revenue
$1.87B
Gross profit
$1.29B
Operating income
$272.7M
Net income
$395.3M
Gross margin
69%
Net margin
21.1%
The company's operating margin has surged by 152% YoY and by 4.3% QoQ
PODD's net income has surged by 69% since the previous quarter
The company's net margin has surged by 61% QoQ
PODD's gross profit is up by 42% YoY and by 5% from the previous quarter

Growth

What is Insulet's growth rate over time

Valuation

What is Insulet stock price valuation
P/E
41.03
P/B
16.26
P/S
8.67
EV/EBIT
54.95
EV/EBITDA
44.09
EV/Sales
8.99
PODD's price to earnings (P/E) is 99% lower than its 5-year quarterly average of 2816.4 and 35% lower than its last 4 quarters average of 63.2
The EPS has soared by 69% from the previous quarter
The equity has soared by 80% YoY and by 26% QoQ
PODD's price to book (P/B) is 63% less than its 5-year quarterly average of 44.2 and 4.9% less than its last 4 quarters average of 17.1
PODD's price to sales (P/S) is 39% lower than its 5-year quarterly average of 14.1 but 14% higher than its last 4 quarters average of 7.6
PODD's revenue is up by 28% year-on-year and by 5% since the previous quarter

Efficiency

How efficient is Insulet business performance
Insulet's return on invested capital has surged by 163% YoY and by 6% QoQ
The ROS has soared by 125% YoY and by 3.1% from the previous quarter
The return on assets has surged by 61% since the previous quarter
PODD's ROE is up by 45% QoQ

Dividends

What is PODD's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for PODD.

Financial health

How did Insulet financials performed over time
The total assets is 53% higher than the total liabilities
The total assets rose by 21% YoY and by 10% QoQ
Insulet's quick ratio has increased by 13% YoY but it has decreased by 2.8% from the previous quarter
The company's debt is 40% higher than its equity
The equity has soared by 80% YoY and by 26% QoQ
The debt to equity has decreased by 44% YoY and by 21% from the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified. Data from and Sharadar.